A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo.
about
Multipurpose prevention technologies: the future of HIV and STI protectionRectal pre-exposure prophylaxis (PrEP)In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition.A MIV-150/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explantsShort communication: a repeated simian human immunodeficiency virus reverse transcriptase/herpes simplex virus type 2 cochallenge macaque model for the evaluation of microbicidesA potent combination microbicide that targets SHIV-RT, HSV-2 and HPVAlternative divalent cations (Zn²⁺, Co²⁺, and Mn²⁺) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity.A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancySustained release of the candidate antiretroviral peptides T-1249 and JNJ54310516-AFP from a rod insert vaginal ringFirst-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease.Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1.An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.
P2860
Q26827796-8CC6942E-BB16-4E15-BAF9-4CF5A1A78156Q26829713-2B1B53D5-BC91-4A41-B33D-AB21ED676AEAQ33978803-0B2B4DDE-265B-4D4E-8F6B-E30FC0192FF4Q34258224-F0FBF21A-F871-4B61-AAB4-360AF861F5EEQ34399737-5FF689EE-E351-4B38-893C-218AEC2F6908Q35150470-35EC9878-7A49-4176-9358-2EEA620E2B37Q35620768-654F3A9E-FEF1-4724-A091-6DDAC4C5A416Q36381485-4FED84D4-1527-45A3-BDB2-09780B3CD03BQ36863834-51781157-FB85-4B0E-9BEE-8189F493936EQ37520083-ED43C6D9-CCE5-4661-A2BA-E122B456AD2CQ38248209-43E25F93-F097-460B-95AE-DD60FBDBEF26Q38700009-ADCFF470-52A1-4023-AF93-4BB7EA39EF83Q39463175-2FA5148B-EA3E-45EB-96F5-9A6FCAFA4B5CQ40081674-C2693FC5-8432-4B7D-B234-4151A94C0EA7Q40165275-D8A1ACB6-EE5A-4538-AD6D-55C6D4790F38
P2860
A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A modified zinc acetate gel, a ...... lex virus 2 infection in vivo.
@en
A modified zinc acetate gel, a ...... lex virus 2 infection in vivo.
@nl
type
label
A modified zinc acetate gel, a ...... lex virus 2 infection in vivo.
@en
A modified zinc acetate gel, a ...... lex virus 2 infection in vivo.
@nl
prefLabel
A modified zinc acetate gel, a ...... lex virus 2 infection in vivo.
@en
A modified zinc acetate gel, a ...... lex virus 2 infection in vivo.
@nl
P2093
P2860
P356
P1476
A modified zinc acetate gel, a ...... lex virus 2 infection in vivo.
@en
P2093
Agegnehu Gettie
Aixa Rodríguez
Gabriela Paglini
James Blanchard
Jeffrey D Lifson
Jessica Kenney
José A Fernández Romero
Keith Levendosky
Larisa Kizima
Melissa Robbiani
P2860
P304
P356
10.1128/AAC.00796-13
P407
P577
2013-06-10T00:00:00Z